3.0
16 Aug 2022
Former employee, more than 1 year
San Francisco, CA
Recommend
CEO approval
Business outlook
Pros
The science was very strong. There is a lot of promise in the technology to isolate and develop unique patient-specific cancer medicine.
Cons
Not enough effort placed on employee retention